RSK-IN-1

• UNSPSC Description:

  RSK-IN-1 (compound 7d) is a RSK inhibitor that inhibits the YB-1 phosphorylation. RSK-IN-1 has anti-tumor effects[1].

• Target Antigen:

  Ribosomal S6 Kinase (RSK); YB-1

• Type:

  Reference compound

• Related Pathways:

  Cell Cycle/DNA Damage;MAPK/ERK Pathway

• Applications:

  Cancer-Kinase/protease

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/rsk-in-1.html

• Solubility:

  10 mM in DMSO

• Smiles:

  CC1=C2C=CC=CC2=C(C=C1)C3=CC=NC=C3C4=CC=C(C(O)=C4)O

• Molecular Weight:

  327.38

• References & Citations:

  [1]Yi-Man Cui, et al. Design, synthesis and anti-breast cancer evaluation of biaryl pyridine analogues as potent RSK inhibitors. Bioorg Med Chem Lett. 2022 Mar 1;59:128565.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2761698-77-3